Precision BioSciences Issues Update Regarding Recent U.S. Patent Office Action Concerning CELLECTIS SA's Patents

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The United States Patent and Trademark Office (PTO) is reexamining two currently issued U.S. patents owned by the Institut Pasteur and the Universite Pierre et Marie Curie, and licensed to Cellectis SA (Alternext: ALCLS). The two patents belong to a family of thirteen issued U.S. patents, which includes U.S. Patent Nos. 7,309,605 and 6,610,545 that are being asserted against Precision BioSciences.

Back to news